Francisella tularensis Schu S4 lipopolysaccharide core sugar and o-antigen mutants are attenuated in a mouse model of tularemia

Infection and Immunity

Volumn 82, Issue 4, 2014, Pages 1523-1539

  Rasmussen, Jed A ^a   Post, Deborah M B ^c   Gibson, Bradford W ^c,d   Lindemann, Stephen R ^b   Apicella, Michael A ^a   Meyerholz, David K ^a   Jones, Bradley D ^a,e  

^a UNIVERSITY OF IOWA   (United States)

^b PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^c BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOPOLYSACCHARIDE; O ANTIGEN;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CONTROLLED STUDY; FRANCISELLA TULARENSIS; GENE LINKAGE DISEQUILIBRIUM; GENE PRODUCT; HISTOPATHOLOGY; IMMUNE RESPONSE; LETHAL DOSE; LUNG PARENCHYMA; MOLECULAR LIBRARY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TRANSPOSON; TULAREMIA;

AMINO ACID SEQUENCE; ANIMALS; BACTERIAL CAPSULES; DISEASE MODELS, ANIMAL; FEMALE; FRANCISELLA TULARENSIS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED C57BL; MUTATION; O ANTIGENS; SEQUENCE ANALYSIS, DNA; TULAREMIA; VIRULENCE; VIRULENCE FACTORS;

EID: 84896456537     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01640-13     Document Type: Article

References (60)

1. McLendon MK, Apicella MA, Allen LA. 2006. Francisella tularensis: taxonomy, genetics, and immunopathogenesis of a potential agent of biowarfare. Annu. Rev. Microbiol. 60:167-185. http://dx.doi.org/10.1146/annurev.micro.60.080805.142126.
2. Tarnvik A, Berglund L. 2003. Tularaemia. Eur. Respir. J. 21:361-373. http://dx.doi.org/10.1183/09031936.03.00088903.
3. Jones CL, Napier BA, Sampson TR, Llewellyn AC, Schroeder MR, Weiss DS. 2012. Subversion of host recognition and defense systems by Francisella spp. Microbiol. Mol. Biol. Rev. 76:383-404. http://dx.doi.org/10.1128/MMBR.05027-11.
4. Fortier AH, Green SJ, Polsinelli T, Jones TR, Crawford RM, Leiby DA, Elkins KL, Meltzer MS, Nacy CA. 1994. Life and death of an intracellular pathogen: Francisella tularensis and the macrophage. Immunol. Ser. 60: 349-361.
5. Conlan JW, North RJ. 1992. Early pathogenesis of infection in the liver with the facultative intracellular bacteria Listeria monocytogenes, Francisella tularensis, and Salmonella typhimurium involves lysis of infected hepatocytes by leukocytes. Infect. Immun. 60:5164-5171.
6. Forestal CA, Benach JL, Carbonara C, Italo JK, Lisinski TJ, Furie MB. 2003. Francisella tularensis selectively induces proinflammatory changes in endothelial cells. J. Immunol. 171:2563-2570.
7. Horzempa J, O'Dee DM, Shanks RM, Nau GJ. 2010. Francisella tularensis ΔpyrF mutants show that replication in nonmacrophages is sufficient for pathogenesis in vivo. Infect. Immun. 78:2607-2619. http://dx.doi.org/10.1128/IAI.00134-10.
8. Lindemann SR, McLendon MK, Apicella MA, Jones BD. 2007. An in vitro model system used to study adherence and invasion of Francisella tularensis live vaccine strain in nonphagocytic cells. Infect. Immun. 75: 3178-3182. http://dx.doi.org/10.1128/IAI.01811-06.
9. Schulert GS, McCaffrey RL, Buchan BW, Lindemann SR, Hollenback C, Jones BD, Allen LA. 2009. Francisella tularensis genes required for inhibition of the neutrophil respiratory burst and intramacrophage growth identified by random transposon mutagenesis of strain LVS. Infect. Immun. 77:1324-1336. http://dx.doi.org/10.1128/IAI.01318-08.
10. Ojeda SS, Wang ZJ, Mares CA, Chang TA, Li Q, Morris EG, Jerabek PA, Teale JM. 2008. Rapid dissemination of Francisella tularensis and the effect of route of infection. BMC Microbiol. 8:215. http://dx.doi.org/10.1186/1471-2180-8-215.
11. Dennis DT, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Friedlander AM, Hauer J, Layton M, Lillibridge SR, McDade JE, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Tonat K, Working Group on Civilian Biodefense. 2001. Tularemia as a biological weapon: medical and public health management. JAMA 285: 2763-2773. http://dx.doi.org/10.1001/jama.285.21.2763.
12. Bosio CM. 2011. The subversion of the immune system by Francisella tularensis. Front. Microbiol. 2:9. http://dx.doi.org/10.3389/fmicb.2011.00009.
13. Phillips NJ, Schilling B, McLendon MK, Apicella MA, Gibson BW. 2004. Novel modification of lipid A of Francisella tularensis. Infect. Immun. 72:5340-5348. http://dx.doi.org/10.1128/IAI.72.9.5340-5348.2004.
14. Vinogradov E, Perry MB, Conlan JW. 2002. Structural analysis of Francisella tularensis lipopolysaccharide. Eur. J. Biochem. 269:6112-6118. http://dx.doi.org/10.1046/j.1432-1033.2002.03321.x.
15. Gunn JS, Ernst RK. 2007. The structure and function of Francisella lipopolysaccharide. Ann. N. Y. Acad. Sci. 1105:202-218. http://dx.doi.org/10.1196/annals.1409.006.
16. Raetz CR. 1990. Biochemistry of endotoxins. Annu. Rev. Biochem. 59: 129-170. http://dx.doi.org/10.1146/annurev.bi.59.070190.001021.
17. Poltorak A, Smirnova I, He X, Liu MY, Van Huffel C, McNally O, Birdwell D, Alejos E, Silva M, Du X, Thompson P, Chan EK, Ledesma J, Roe B, Clifton S, Vogel SN, Beutler B. 1998. Genetic and physical mapping of the Lps locus: identification of the Toll-4 receptor as a candidate gene in the critical region. Blood Cells Mol. Dis. 24:340-355. http://dx.doi.org/10.1006/bcmd.1998.0201.
18. Beutler B, Poltorak A. 2000. Positional cloning of Lps, and the general role of Toll-like receptors in the innate immune response. Eur. Cytokine Netw. 11:143-152.
19. Hajjar AM, Harvey MD, Shaffer SA, Goodlett DR, Sjostedt A, Edebro H, Forsman M, Bystrom M, Pelletier M, Wilson CB, Miller SI, Skerrett SJ, Ernst RK. 2006. Lack of in vitro and in vivo recognition of Francisella tularensis subspecies lipopolysaccharide by Toll-like receptors. Infect. Immun. 74:6730-6738. http://dx.doi.org/10.1128/IAI.00934-06.
20. Clay CD, Soni S, Gunn JS, Schlesinger LS. 2008. Evasion of complement- mediated lysis and complement C3 deposition are regulated by Francisella tularensis lipopolysaccharide O antigen. J. Immunol. 181: 5568-5578.
21. Hood AM. 1977. Virulence factors of Francisella tularensis. J. Hyg. 79:47-60. http://dx.doi.org/10.1017/S0022172400052840.
22. Sandstrom G, Lofgren S, Tarnvik A. 1988. A capsule-deficient mutant of Francisella tularensis LVS exhibits enhanced sensitivity to killing by serum but diminished sensitivity to killing by polymorphonuclear leukocytes. Infect. Immun. 56:1194-1202.
23. Apicella MA, Post DM, Fowler AC, Jones BD, Rasmussen JA, Hunt JR, Imagawa S, Choudhury B, Inzana TJ, Maier TM, Frank DW, Zahrt TC, Chaloner K, Jennings MP, McLendon MK, Gibson BW. 2010. Identification, characterization and immunogenicity of an O-antigen capsular polysaccharide of Francisella tularensis. PLoS One 5:e11060. http://dx.doi.org/10.1371/journal.pone.0011060.
24. Whitfield C, Kaniuk N, Frirdich E. 2003. Molecular insights into the assembly and diversity of the outer core oligosaccharide in lipopolysaccharides from Escherichia coli and Salmonella. J. Endotoxin Res. 9:244-249. http://dx.doi.org/10.1177/09680519030090040501.
25. Lindemann SR, Peng K, Long ME, Hunt JR, Apicella MA, Monack DM, Allen LA, Jones BD. 2011. Francisella tularensis Schu S4 O-antigen and capsule biosynthesis gene mutants induce early cell death in human macrophages. Infect. Immun. 79:581-594. http://dx.doi.org/10.1128/IAI.00863-10.
26. Pavlov VM, Mokrievich AN, Volkovoy K. 1996. Cryptic plasmid pFNL10 from Francisella novicida-like F6168: the base of plasmid vectors for Francisella tularensis. FEMS Immunol. Med. Microbiol. 13:253-256. http://dx.doi.org/10.1111/j.1574-695X.1996.tb00247.x.
27. McLendon MK, Schilling B, Hunt JR, Apicella MA, Gibson BW. 2007. Identification of LpxL, a late acyltransferase of Francisella tularensis. Infect. Immun. 75:5518-5531. http://dx.doi.org/10.1128/IAI.01288-06.
28. Ciucanu I. 2006. Per-O-methylation reaction for structural analysis of carbohydrates by mass spectrometry. Anal. Chim. Acta 576:147-155. http://dx.doi.org/10.1016/j.aca.2006.06.009.
29. Allen S, Zaleski A, Johnston JW, Gibson BW, Apicella MA. 2005. Novel sialic acid transporter of Haemophilus influenzae. Infect. Immun. 73: 5291-5300. http://dx.doi.org/10.1128/IAI.73.9.5291-5300.2005.
30. Gibson-Corley KN, Olivier AK, Meyerholz DK. 2013. Principles for valid histopathologic scoring in research. Vet. Pathol. 50:1007-1015. http://dx.doi.org/10.1177/0300985813485099.
31. Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, Lopez R, McWilliam H, Remmert M, Soding J, Thompson JD, Higgins DG. 2011. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol. Syst. Biol. 7:539. http://dx.doi.org/10.1038/msb.2011.75.
32. Schild S, Lamprecht AK, Reidl J. 2005. Molecular and functional characterization of O antigen transfer in Vibrio cholerae. J. Biol. Chem. 280: 25936-25947. http://dx.doi.org/10.1074/jbc.M501259200.
33. Perez JM, McGarry MA, Marolda CL, Valvano MA. 2008. Functional analysis of the large periplasmic loop of the Escherichia coli K-12 WaaL O-antigen ligase. Mol. Microbiol. 70:1424-1440. http://dx.doi.org/10.1111/j.1365-2958.2008.06490.x.
34. Islam ST, Taylor VL, Qi M, Lam JS. 2010. Membrane topology mapping of the O-antigen flippase (Wzx), polymerase (Wzy), and ligase (WaaL) from Pseudomonas aeruginosa PAO1 reveals novel domain architectures. mBio 1:e00189-10. http://dx.doi.org/10.1128/mBio.00189-10.
35. Tusnady GE, Simon I. 1998. Principles governing amino acid composi- tion of integral membrane proteins: application to topology prediction. J. Mol. Biol. 283:489-506. http://dx.doi.org/10.1006/jmbi.1998.2107.
36. Tusnady GE, Simon I. 2001. The HMMTOP transmembrane topology prediction server. Bioinformatics 17:849-850. http://dx.doi.org/10.1093/bioinformatics/17.9.849.
37. Spyropoulos IC, Liakopoulos TD, Bagos PG, Hamodrakas SJ. 2004. TMRPres2D: high quality visual representation of transmembrane protein models. Bioinformatics 20:3258-3260. http://dx.doi.org/10.1093/bioinformatics/bth358.
38. Hong M, Payne SM. 1997. Effect of mutations in Shigella flexneri chromosomal and plasmid-encoded lipopolysaccharide genes on invasion and serum resistance. Mol. Microbiol. 24:779-791. http://dx.doi.org/10.1046/j.1365-2958.1997.3731744.x.
39. Ohno A, Isii Y, Tateda K, Matumoto T, Miyazaki S, Yokota S, Yamaguchi K. 1995. Role of LPS length in clearance rate of bacteria from the bloodstream in mice. Microbiology 141:2749-2756. http://dx.doi.org/10.1099/13500872-141-10-2749.
40. Rietschel ET. 1984. Chemistry of endotoxin. Elsevier, New York, NY.
41. Pradel E, Parker CT, Schnaitman CA. 1992. Structures of the rfaB, rfaI, rfaJ, and rfaS genes of Escherichia coli K-12 and their roles in assembly of the lipopolysaccharide core. J. Bacteriol. 174:4736-4745.
42. Vinogradov E, Conlan WJ, Gunn JS, Perry MB. 2004. Characterization of the lipopolysaccharide O-antigen of Francisella novicida (U112). Carbohydr. Res. 339:649-654. http://dx.doi.org/10.1016/j.carres.2003.12.013.
43. Reed LJ, Muench H. 1938. A simple method of estimating fifty per cent endpoints. Am. J. Epidemiol. 27:493-497.
44. Wang X, Ribeiro AA, Guan Z, McGrath SC, Cotter RJ, Raetz CR. 2006. Structure and biosynthesis of free lipid A molecules that replace lipopolysaccharide in Francisella tularensis subsp. novicida. Biochemistry 45: 14427-14440. http://dx.doi.org/10.1021/bi061767s.
45. Raetz CR, Guan Z, Ingram BO, Six DA, Song F, Wang X, Zhao J. 2009. Discovery of new biosynthetic pathways: the lipid A story. J. Lipid Res. 50(Suppl):S103-S108. http://dx.doi.org/10.1194/jlr.R800060-JLR200.
46. Raetz CR, Reynolds CM, Trent MS, Bishop RE. 2007. Lipid A modification systems in gram-negative bacteria. Annu. Rev. Biochem. 76:295-329. http://dx.doi.org/10.1146/annurev.biochem.76.010307.145803.
47. McDonald MK, Cowley SC, Nano FE. 1997. Temperature-sensitive lesions in the Francisella novicida valA gene cloned into an Escherichia coli msbA lpxK mutant affecting deoxycholate resistance and lipopolysaccharide assembly at the restrictive temperature. J. Bacteriol. 179:7638- 7643.
48. Bos MP, Tefsen B, Geurtsen J, Tommassen J. 2004. Identification of an outer membrane protein required for the transport of lipopolysaccharide to the bacterial cell surface. Proc. Natl. Acad. Sci. U. S. A. 101:9417-9422. http://dx.doi.org/10.1073/pnas.0402340101.
49. Genevrois S, Steeghs L, Roholl P, Letesson JJ, van der Ley P. 2003. The Omp85 protein of Neisseria meningitidis is required for lipid export to the outer membrane. EMBO J. 22:1780-1789. http://dx.doi.org/10.1093/emboj/cdg174.
50. Tran AX, Trent MS, Whitfield C. 2008. The LptA protein of Escherichia coli is a periplasmic lipid A-binding protein involved in the lipopolysaccharide export pathway. J. Biol. Chem. 283:20342-20349. http://dx.doi.org/10.1074/jbc.M802503200.
51. Mulford CA, Osborn MJ. 1983. An intermediate step in translocation of lipopolysaccharide to the outer membrane of Salmonella typhimurium. Proc. Natl. Acad. Sci. U. S. A. 80:1159-1163. http://dx.doi.org/10.1073/pnas.80.5.1159.
52. Alexander DC, Valvano MA. 1994. Role of the rfe gene in the biosynthesis of the Escherichia coli O7-specific lipopolysaccharide and other O-specific polysaccharides containing N-acetylglucosamine. J. Bacteriol. 176:7079- 7084.
53. Keenleyside WJ, Whitfield C. 1996. A novel pathway for O-polysaccharide biosynthesis in Salmonella enterica serovar Borreze. J. Biol. Chem. 271:28581-28592. http://dx.doi.org/10.1074/jbc.271.45.28581.
54. Lehrer J, Vigeant KA, Tatar LD, Valvano MA. 2007. Functional characterization and membrane topology of Escherichia coli WecA, a sugarphosphate transferase initiating the biosynthesis of enterobacterial common antigen and O-antigen lipopolysaccharide. J. Bacteriol. 189:2618-2628. http://dx.doi.org/10.1128/JB.01905-06.
55. Kim TH, Sebastian S, Pinkham JT, Ross RA, Blalock LT, Kasper DL. 2010. Characterization of the O-antigen polymerase (Wzy) of Francisella tularensis. J. Biol. Chem. 285:27839-27849. http://dx.doi.org/10.1074/jbc.M110.143859.
56. Leyman B, Boyen F, Van Parys A, Verbrugghe E, Haesebrouck F, Pasmans F. 2011. Salmonella Typhimurium LPS mutations for use in vaccines allowing differentiation of infected and vaccinated pigs. Vaccine 29:3679-3685. http://dx.doi.org/10.1016/j.vaccine.2011.03.004.
57. Billips BK, Yaggie RE, Cashy JP, Schaeffer AJ, Klumpp DJ. 2009. A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli. J. Infect. Dis. 200:263-272. http://dx.doi.org/10.1086/599839.
58. Okan NA, Chalabaev S, Kim TH, Fink A, Ross RA, Kasper DL. 2013. Kdo hydrolase is required for Francisella tularensis virulence and evasion of TLR2-mediated innate immunity. mBio 4:e00638-12. http://dx.doi.org/10.1128/mBio.00638-12.
59. Chalabaev S, Kim TH, Ross R, Derian A, Kasper DL. 2010. 3-Deoxy- D-manno-octulosonic acid (Kdo) hydrolase identified in Francisella tularensis, Helicobacter pylori, and Legionella pneumophila. J. Biol. Chem. 285:34330-34336. http://dx.doi.org/10.1074/jbc.M110.166314.
60. Zarrella TM, Singh A, Bitsaktsis C, Rahman T, Sahay B, Feustel PJ, Gosselin EJ, Sellati TJ, Hazlett KRO. 2011. Host-adaptation of Francisella tularensis alters the bacterium's surface-carbohydrates to hinder effectors of innate and adaptive immunity. PLoS One 6:e22335. http://dx.doi.org/10.1371/journal.pone.0022335.